Avidity Biosciences's total assets for Q1 2025 were $1.46B, a decrease of -6.70% from the previous quarter. RNA total liabilities were $130.35M for the fiscal quarter, a -6.18% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.